Recommended Stocks for June 2025
In the past trading week, numerous experts have highlighted various stocks as particularly recommended for private investors. These recommendations are based on potential growth, stable returns, and attractive valuations.
Top Stocks According to Experts
1. Infineon
Deutsche Bank Research has raised the target price for Infineon from 38 to 42 euros and maintained its rating of “Buy,” making the stock a favorite among analysts.
2. TUI
The British investment bank Barclays has increased the target price for TUI from 7.70 to 11.00 euros and changed its rating from “Underweight” to “Overweight.” This signals a strong growth potential for the travel group.
3. Siemens Energy
Siemens Energy continues to be rated with a “Buy” rating, with a target price of 100 euros according to Deutsche Bank Research.
4. BMW
UBS continues to recommend buying BMW and sees further potential in the automobile manufacturer.
Other Interesting Stock Recommendations
- Uber Technologies: Market leader in ridesharing and delivery services with strong revenue growth and high free cash flow. Despite risks posed by autonomous vehicles, Uber is considered well-positioned.
- AI Stocks: Particularly exciting companies in artificial intelligence currently include Snowflake, Nvidia, Microsoft, and Broadcom.
- Dividend Stocks: For investors focused on stable income, US dividend stocks such as Valley National Bancorp, Universal, or Peoples Bancorp are appealing.
- Other Top Companies: Pfizer, Campbell Soup Company, Yum China Holdings, and Thermo Fisher Scientific are also recommended for their stable business models and growth prospects.
This selection showcases a wide range of industries – from technology to energy to consumer goods – that are currently highly favored by experts and promise both growth opportunities and stable returns.
Summary
For private investors, particularly interesting stocks may include: Infineon, TUI, Siemens Energy, BMW, Uber Technologies, AI-focused stocks like Nvidia or Microsoft, and stable dividend payers from the US market. These recommendations reflect current assessments and can help build a diversified portfolio with opportunities for sustainable growth and regular returns.